OptiRTP CEO Jon Doherty and Founder & CTO Bogdan Anich met with the United States Consulate General and the U.S. Commercial Service in Auckland on 4 March 2026 to discuss the company’s United States market strategy.

The meeting included U.S. Consul General Melissa Sweeney, Senior Commercial Officer–Oceania Steve Knode, visiting from the U.S. Commercial Service office in Sydney, and Jonathan Watt, Commercial Specialist with the U.S. Commercial Service in Auckland. U.S.-based COO Sharyn Harper joined via video from Ohio, where she is leading the company’s U.S. operational development.

During the discussion, Harper outlined OptiRTP’s planned sequence for entering and expanding in the United States, including the operational steps the company is taking to establish its presence, build partnerships across key sectors, and progress its intended FDA De Novo regulatory pathway.

The meeting coincided with Knode’s visit to New Zealand and formed part of OptiRTP’s ongoing engagement with the U.S. Commercial Service, which assists companies in navigating the process of setting up and growing operations in the U.S. market. OptiRTP continues to advance its United States market strategy across regulatory, operational, and partnership workstreams.